Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF00662134.pdf
Reference28 articles.
1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1?15,71-85, 1992.
2. Hillner BE, Smith TJ: Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. N Engl J Med 324:160?168, 1991.
3. Hillner BE, Smith TJ: Should women with node-negative breast cancer receive adjuvant chemotherapy? ? Insights from a decision analysis model. Breast Cancer Res Treat 23:17?27, 1992.
4. Smith TJ, Hillner BE: The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. J Clin Oncol, in press.
5. Desch CE, Hillner BE, Smith TJ, Retchin SM: Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life expectancy outcomes. J Clin Oncol, in press.
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Economic evaluations of oral medications for breast cancer treatment in the U.S.: a systematic review with a focus on cost-effectiveness threshold;Expert Review of Pharmacoeconomics & Outcomes Research;2019-10-25
2. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?;The Breast Journal;2017-01-24
3. Cancer in Low- and Middle-Income Countries: An Economic Overview;Disease Control Priorities, Third Edition (Volume 3): Cancer;2015-11
4. Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan;British Journal of Cancer;2009-01
5. Costs of Adjuvant Breast Cancer Treatments;Adjuvant Therapy for Breast Cancer;2009
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3